Trial Profile

Treatment of plasma cell leukemia in patients under 70 years [Traitement des leucémies primitives à plasmocytes du sujets de moins de 70 ans]

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 02 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bortezomib (Primary) ; Doxorubicin liposomal (Primary) ; Lenalidomide (Primary)
Indications Plasma cell leukaemia
Focus Therapeutic Use
Acronyms AOL09-DrROYER

Most Recent Events

25 Apr 2016 Status changed from active, no longer recruiting to completed according to results published in the Journal of Clinical Oncology.
25 Apr 2016 Results published in the Journal of Clinical Oncology
01 Jul 2013 Status changed from recruiting to active, no longer recruiting according to results published in the Journal of Clinical Oncology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com